Pharmafile Logo
Pharmafocus logo
Advanced Search
lilly_scientists

Lilly increases Alzheimer’s R&D

April 18, 2013
Research and Development, Sales and Marketing Alzheimer's, lilly

Eli Lilly and Company has bought a new diagnostic technology which may help point to a different way of treating …

News

Oxford Cancer Biomarkers signs discovery deal with AstraZeneca

April 18, 2013
Research and Development AstraZeneca, Oxford Cancer Biomarkers

AstraZeneca has signed a new alliance with a UK firm in the field of biomarker discovery.Oxford Cancer Biomarkers is developing …

News
yoosuk

Teva-Handok names chief executive

April 17, 2013
Manufacturing and Production, Research and Development, Sales and Marketing teva-handok

Teva-Handok has announced the appointment of Yoo Suk Hong as the first chief executive of the business venture between Teva …

Appointment
lilly_corporate_hq

Lilly Phase III diabetes boost

April 17, 2013
Research and Development, Sales and Marketing diabetes, dulaglutide, lilly

Eli Lilly and Co’s new type II diabetes candidate dulaglutide – which it intends to file this year – has …

News
Caan image

Dragon’s Den entrepreneur expands into healthcare

April 17, 2013
Medical Communications, Research and Development, Sales and Marketing Dragon's den, ab prime advantage, james caan

James Caan, one of the panel of entrepreneurs on TV’s Dragons’ Den, is to expand his business into the healthcare …

News

Zeno Group hires Rachel Vrettos to lead UK healthcare practice

April 17, 2013
Medical Communications, Sales and Marketing Red Door, zeno group

PR agency Zeno Group has confirmed the appointment of Rachel Vrettos as director, Healthcare for its UK operations. Vrettos has …

Appointment

Mobilising for action in consumer healthcare

April 16, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing A.T. Kearney, healthcare products, marketing

A new market of consumer-focused healthcare products is emerging to occupy the space between consumer goods and pharmaceuticals – and …

Feature
abpi_reception_close

OHE: drugs spend to rise

April 16, 2013
Medical Communications, Sales and Marketing ABPI, OHE

UK medicines expenditure is set to grow between 3.1% and 4.1% by 2015, according to a study which the researchers …

News
675275-nouveau-president-chef-direction-aeterna

New president and chief executive for Aeterna Zentaris

April 16, 2013
Manufacturing and Production, Research and Development, Sales and Marketing aeterna zentaris

Aeterna Zentaris has announced that David Dodd has been appointed as its president and chief executive, succeeding Juergen Engel. Dodd …

Appointment

Celgene appoints new Haematology head

April 15, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, browne

Celgene has announced the appointment of Karen Browne as business unit director of Haematology, Celgene UK and Ireland. Over the …

Appointment

ANI poised to take over BioSante

April 15, 2013
Sales and Marketing ANI, biosante

US firms BioSante Pharmaceuticals and ANI Pharmaceuticals have tweaked the terms of the merger they announced last year, and which …

News
celgene_hugin

Big pharma appointments to PhRMA Board

April 15, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, Celgene, Merck, Pfizer, PhRMA

Chairman and chief executive of Celgene Robert Hugin has been elected chairman of the Pharmaceutical Research and Manufacturers of America …

Appointment

Eisai appoints chief clinical officer

April 12, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Eisai

Eisai has announced the immediate appointment of Lynn Kramer to the newly created position of chief clinical officer of Eisai …

Appointment
tamiflu

Cancer drugs boost Roche

April 12, 2013
Sales and Marketing Cancer, Q1, Roche

Roche saw overall sales rise 6% year-on-year in the first three months of this year on the back of a …

News
nhs_trees

Change at centre of NHS plan

April 12, 2013
Sales and Marketing Mid Staffs, NHS, putting patients first

The shadow of Mid Staffs looms long over NHS England’s new three-year business plan, with a move towards fundamental change …

News
roche_close

Roche signs Huntington’s deal

April 10, 2013
Research and Development, Sales and Marketing Huntington's, Isis, Roche

Roche is to pay California-based Isis Pharmaceuticals $30 million upfront to cement a new alliance in which the firms will …

News

Bristol-Myers Squibb appoints executive as another retires

April 10, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS

Bristol-Myers Squibb has announced the appointment of Francis Cuss as executive VP and chief scientific officer following Elliott Sigal’s intentions …

Appointment

MedImmune buys AlphaCore

April 9, 2013
Research and Development AlphaCore, AstraZeneca, MedImmune

AstraZeneca’s biologics R&D arm MedImmune has bought private US biotech firm AlphaCore Pharma for an undisclosed sum.The acquisition is part …

News

Pharma pays doctors £40m

April 9, 2013
Sales and Marketing ABPI, Bad pharma, ethics

Health professionals received £40 million in payments from pharma companies last year, according to new figures released by the ABPI.This …

News

New head at European Medicines Agency

April 8, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA

The European Medicines Agency has appointed Agneta Brandt as the new head of Infrastructure Services. Brandt joins the Agency from …

Appointment
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026